4d Pharma Share Discussion Threads

[vlad the impaler] 28/6/2022 12:39

"One must always ponder the behaviour of one side, as they later lick their wounds "

It was not sweet ...

[katsy] 28/6/2022 12:39

Vlad do us a favour, we're all hurting here. We can't change what's happened. Please stop making it worse for us.

[vlad the impaler] 28/6/2022 12:36

Indeed no. Im not trying to get any credit post event. You need to look to posters pre event for that lol

I think I remember some poster saying it was coming, and getting hammered. What was the point ?

[georgethefourth] 28/6/2022 12:32

Vlad - you’re being “slaughtered” because you’re not saying anything. The company goes into administration because of bad terms on the OF loan and then you turn up - after the event - and post 700 posts which amount to “it was obvious that would happen”. It seems like you’re trying to get credit for being some financial guru by saying I told you so -even though you only told us after the event. You also show a complete lack of class. Who turns up on a board after something like this has happened and posts repeated negative stuff. What’s the point?

[vlad the impaler] 28/6/2022 12:18

Best thing to do now is just write it off. Market feeds on hope

Start again


But smarter

[vlad the impaler] 28/6/2022 12:14

Wowwwwww

Slaughtered by the ones you believed in, and I'm the enemy?

😂😂

[vlad the impaler] 28/6/2022 12:14

Not knocking anyone
Simply saying don't run into a similar arena to recoup

Human nature to

Bad idea

[vlad the impaler] 28/6/2022 12:10

Or just party money ?

[williamcooper104] 28/6/2022 12:10

Found someone who said they'd lend money if a load of equity went in Not surprised OF pulled the plug

[vlad the impaler] 28/6/2022 12:10

Actually makes one question , were you intentionally sold down the river?

[vlad the impaler] 28/6/2022 12:08

Must have been bad if his background went for that Financial deal

[vlad the impaler] 28/6/2022 12:07

Mr. Duncan Joseph Peyton is a Co-founder of Retroscreen Virology Group plc. Mr. Peyton serves as Chief Executive Officer at 4D pharma plc. since February 2014.
Mr. Peyton served at Aquarius Equity Partners Ltd. He founded Aquarius Equity Partners in 2005 and serves as its Founder Partner. He involved in coordinating the fundraising, investment, and regulatory and compliance teams. He has overall responsibility for the sustainability of the successful track record and his focus is on investment and portfolio management.
He has a wide range of abilities. He served as a Corporate Finance Lawyer at Addleshaw Booth & Co specializing in private equity transactions. He served as an Investment Manager of 3i Group plc, where he was involved with several hi-technology investments. He is a qualified lawyer, investment director and scientist, having started his career in a bio-science start-up business, which ultimately went on to list on the London Stock Exchange.

[vlad the impaler] 28/6/2022 12:03

Answer probably there

[vlad the impaler] 28/6/2022 12:03

What size holding had the CEO?

[vlad the impaler] 28/6/2022 12:02

Ccnsidering the words of the CEO for weeks prior to news, this one has got to be classed as, at best, gross negligence , or as bad as, straight forward fraud

[frrinvest] 28/6/2022 12:00

Stoner ... no more than a dozen PIs attended the AGM

[vlad the impaler] 28/6/2022 11:56

I'm afraid frrinvest, the saddos are the ones who told everyone to buy it.
But by all means, pass the buck 😂

[frrinvest] 28/6/2022 11:55

AGM results will probably be posted this PM. This board is too toxic for me, a few real saddos and vulturs about here.

This is the summary from one LSE shareholder who attended the meeting too....

Right. Here goes. Duncan looked awful so clearly feeling it. Lots of questions put to Duncan who answered everything. Oxford Finance pulled the deal even though the company had a heads of terms to refinance with a mix of debt and equity. OF knew that but still pulled the plug. The admin guy was there too who said they are trying to rescue this finance deal which will sort everything, they are also talking to OF but the admin guy said a deal
is unlikely. It rests on this finance deal short term, longer term it is about trying other refinance or offers for assets. If it comes to offers, admin are mostly bothered about getting OF and other creditors repaid. Shareholders bottom of the pile. Duncan was asked if they prepack, there will be a lot of very angry shareholders. Duncan said no plans for that, he is a shareholder as is Alex and they want to save 4D. The company did breach on 2 counts. They renegotiated the $7.5m to $5m but had it held in 2 US accounts rather than 1. Technical breech as they could have easily moved the money into one. One shareholder asked the admin guy if they had gone below $5m privately . He said they had. So major breech. They also breeched a balance sheet criteria because the non plc companies held too much in their balance sheet when the Spanish government made a one off payment to cover furlough workers in Spain during Covid. We are where we are. In hindsight Duncan should have done a placing but he had no idea the capital markets would be so difficult. As asked about milestone payments. They think Merck will licence 3 drugs from the JV vaccine work which attracts 5-10m
US$ each. I asked if that could be accelerated. Duncan is in discussions with Merck but said they don’t work quickly. One shareholder who is a scientist with a huge holding asked Duncan after the AGM when Duncan came round and shook hands with Alex and asked if there were any more questions before we left, from 1-10 Duncan , what are your thoughts thus will be saved to trade on AIM, Duncan replied, a very good chance. I hope he is right.

[vlad the impaler] 28/6/2022 11:54

Genuine question